JUNS

Latest SEC Filings & News for JUNS

1 most recent filing and news item mentioning JUNS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/JUNS/news?limit=20"

Pull JUNS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

M&AMay 20, 2026Positive

Jupiter Neurosciences secures $100M term sheet for ALA-002 MDMA rights

Jupiter Neurosciences entered into a term sheet to acquire exclusive U.S. rights to PharmAla's ALA-002, a next-generation MDMA therapeutic, with an upfront payment of $3.33 million and milestone payments. The transaction positions the company to capitalize on President Trump's ex

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.